Plain-English translation of NCT07491848 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how hepatitis B and D infection affects your mouth and gums, and whether a medication called helps reduce inflammation in oral tissues. This study will compare three groups: patients with hepatitis B+D taking , patients with hepatitis B+D not taking it, and healthy people without the infection. By collecting saliva and fluid samples from your mouth and examining your gums, scientists hope to discover new connections between liver disease and oral health.
People with hepatitis B and D often have ongoing inflammation throughout their body, but doctors don't know much about how this affects oral health or whether this medication helps reduce inflammation in the mouth. Understanding these connections could lead to better care for patients with both conditions.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic at the start of the study and again after 6 months. Each visit involves a thorough examination of your mouth and gums by a dental specialist, photography of your oral cavity, and collection of saliva and gum fluid using simple, non-invasive methods. The researchers will also review your medical records (following strict privacy rules) to gather relevant health information. Your samples will be analyzed in laboratories to measure signs of inflammation.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Romania